Angle (AGL)

Angle Plc
Sort by:
 Showing the most relevant articles for your search:LSE:AGL
05/20/20223:48AMAlliance NewsIN BRIEF: Cancer study using Angle's Parasortix secures funding LSE:AGLAngle Plc
05/20/20221:01AMRNS Non-RegulatoryAngle PLC Prostate Cancer UK funds new study using Parsortix LSE:AGLAngle Plc
04/28/202210:10AMAlliance NewsEARNINGS UPDATES: Brave Bison notes first profit; Angle widens loss LSE:AGLAngle Plc
04/28/20221:02AMUK Regulatory (RNS & others)Angle PLC Preliminary Results LSE:AGLAngle Plc
04/20/20221:11AMUK Regulatory (RNS & others)Angle PLC Notice of Preliminary Results and Webcast LSE:AGLAngle Plc
04/14/20221:11AMRNS Non-RegulatoryAngle PLC Poster on Parsortix system presented at AACR 2022 LSE:AGLAngle Plc
04/01/20227:25AMAlliance NewsTRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt tops forecast LSE:AGLAngle Plc
04/01/20221:01AMRNS Non-RegulatoryAngle PLC Identifying drug targets in cancer metastasis LSE:AGLAngle Plc
03/29/20222:29PMAlliance NewsIN BRIEF: Angle's Parsortix can help with cancer treatment options LSE:AGLAngle Plc
03/29/20221:01AMRNS Non-RegulatoryAngle PLC Rapid information on patient response to therapies LSE:AGLAngle Plc
03/25/20221:51PMAlliance NewsTRADING UPDATES: Europa eyes fundraise; Eastinco extends long stop LSE:AGLAngle Plc
03/25/20222:00AMRNS Non-RegulatoryAngle PLC Identifying therapeutic targets in TNBC patients LSE:AGLAngle Plc
03/18/20223:38PMAlliance NewsTRADING UPDATES: Angle US lab boost; Corcel to capitalise on nickel LSE:AGLAngle Plc
03/15/20222:00AMRNS Non-RegulatoryAngle PLC Update on laboratory accreditation LSE:AGLAngle Plc
03/09/202210:41AMUK Regulatory (RNS & others)Angle PLC Second Price Monitoring Extn LSE:AGLAngle Plc
03/09/202210:36AMUK Regulatory (RNS & others)Angle PLC Price Monitoring Extension LSE:AGLAngle Plc
03/02/202212:29PMUK Regulatory (RNS & others)Angle PLC Holding(s) in Company LSE:AGLAngle Plc
02/18/202211:13AMUK Regulatory (RNS & others)Angle PLC Issue of Equity LSE:AGLAngle Plc
01/21/20226:25AMAlliance NewsTAKING AIM: Berenberg hails Angle's cancer diagnosis offering LSE:AGLAngle Plc
01/21/20224:57AMAlliance NewsStudy shows potential for Angle's Parsortix system in clinical trials LSE:AGLAngle Plc
01/21/20221:00AMRNS Non-RegulatoryAngle PLC Potential in immunotherapy treatment selection LSE:AGLAngle Plc
01/17/20229:16AMAlliance NewsAngle says Parsortix system could replace cancer tissue biopsy LSE:AGLAngle Plc
01/17/20221:01AMRNS Non-RegulatoryAngle PLC Concordance of Parsortix with tissue biopsy LSE:AGLAngle Plc
01/13/20226:06AMAlliance NewsAngle cancer study delayed as accreditation process for labs starts LSE:AGLAngle Plc
01/13/20221:00AMUK Regulatory (RNS & others)Angle PLC Update on lab accreditation and ovarian study LSE:AGLAngle Plc
01/10/20221:34PMAlliance NewsTRADING UPDATES: Harvest Minerals sales jump; Quartix earnings to rise LSE:AGLAngle Plc
01/10/20221:00AMRNS Non-RegulatoryAngle PLC Insight into drug resistance in NSCLC LSE:AGLAngle Plc
12/22/202112:29PMUK Regulatory (RNS & others)Angle PLC Issue of Equity LSE:AGLAngle Plc
12/01/202112:10PMUK Regulatory (RNS & others)Angle PLC Issue of Equity LSE:AGLAngle Plc
12/01/20211:00AMRNS Non-RegulatoryAngle PLC Parsortix in RNA analysis of CTCs as tool in NSCLC LSE:AGLAngle Plc
 Showing the most relevant articles for your search:LSE:AGL
Your Recent History
Ivanhoe Mi..
Canadian D..
Xumanii In..
Euro vs Ca..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20220522 05:23:31